Pulmonary vein isolation using pulsed field ablation vs. high-power short-duration radiofrequency ablation in paroxysmal atrial fibrillation: efficacy, safety, and long-term follow-up (PRIORI study)
Europace · 02.07.2024 · 26 (7)
DOI: 10.1093/europace/euae194 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Europace, online erschienen am 12.07.2024. Verfasst von Nico Reinsch und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrophysiology, Alfried Krupp Krankenhaus, Alfried-Krupp-Straße 21, 45131 Essen, Germany. Hauptthemen laut MEDLINE: Atrial Fibrillation, Pulmonary Veins. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aims
Pulsed field ablation (PFA) is a novel, non-thermal, cardiac tissue-selective ablation modality. To date, radiofrequency (RF)-guided high-power short-duration (HPSD) ablation represents the gold standard besides cryo-ablation for pulmonary vein isolation (PVI). This single-centre, retrospective study investigated the efficacy of PFA-PVI vs. HPSD-RF PVI in terms of single-procedure arrhythmia-free outcome and safety in a real-world setting. Methods and results Consecutive, paroxysmal atrial fibrillation (AF) patients who underwent PVI using PFA or HPSD-RF were enrolled. In group PFA, PVI was performed using a pentaspline PFA catheter. The ablation procedure in group HPSD-RF was performed with RF energy (45 W, ablation index). A total of 410 patients (group PFA, 201; group HPSD-RF, 209) were included. There was no difference between both groups regarding age, gender, and CHA2DS2-VASc score. The procedure time was significantly shorter in group PFA [61 (44–103) vs. 125 (105–143) min; P < 0.001]; fluoroscopy time and dose area product were significantly higher in group PFA [16 (13–20) vs. 4 (2–5) min; P < 0.01 and 412 (270–739) vs. 129 (58–265) μGym2; P < 0.01]. The overall complication rates were 2.9% in group PFA and 6.2% in group HPSD (P = 0.158). There was one fatal stroke in the PFA group. The 1-year Kaplan–Meier estimated freedom from any atrial tachyarrhythmia was 85% with PFA and 79% with HPSD-RF (log-rank P = 0.160). In 56 repeat ablation procedures, the PV reconnection rate was 30% after PFA and 38% after HPSD-RF (P = 0.372).
Conclusion
Both PFA and HPSD-RF were highly efficient and effective in achieving PVI in paroxysmal AF patients. The arrhythmia-free survival is comparable. The PV reconnection rate was not different.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Electrophysiology, Alfried Krupp Krankenhaus, Alfried-Krupp-Straße 21, 45131 Essen, Germany.
- Department of Medicine, Witten/Herdecke University, Alfred-Herrhausen-Straße 50, 58448 Witten, Germany.
- Department of Cardiology, St. Marienhospital Vechta, Vechta, Germany.
- Department of Oncology, Gastroenterology and Hematology, Alfried Krupp Krankenhaus, Essen, Germany.
ORCID-Profile: Nico Reinsch, Anna Füting, Stefan Hartl, Dennis Höwel, Karampet Kasparian, Kars Neven
Zitieren
APA
Reinsch, N., Füting, A., Hartl, S., Höwel, D., Rausch, E., Lin, Y., Kasparian, K., & Neven, K. (2024). Pulmonary vein isolation using pulsed field ablation vs. high-power short-duration radiofrequency ablation in paroxysmal atrial fibrillation: efficacy, safety, and long-term follow-up (PRIORI study). Europace, 26(7). https://doi.org/10.1093/europace/euae194
Vancouver
Reinsch N, Füting A, Hartl S, Höwel D, Rausch E, Lin Y, et al. Pulmonary vein isolation using pulsed field ablation vs. high-power short-duration radiofrequency ablation in paroxysmal atrial fibrillation: efficacy, safety, and long-term follow-up (PRIORI study). Europace. 2024;26(7). doi:10.1093/europace/euae194
BibTeX
@article{Reinsch2024,
author = {Reinsch, Nico and Füting, Anna and Hartl, Stefan and Höwel, Dennis and Rausch, Eva and Lin, Yali and Kasparian, Karampet and Neven, Kars},
title = {Pulmonary vein isolation using pulsed field ablation vs. high-power short-duration radiofrequency ablation in paroxysmal atrial fibrillation: efficacy, safety, and long-term follow-up (PRIORI study)},
journal = {Europace},
year = {2024},
volume = {26},
number = {7},
doi = {10.1093/europace/euae194}
}
EUVIMED